These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 31504595)
1. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations. Truver MT; Palmquist KB; Swortwood MJ J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595 [TBL] [Abstract][Full Text] [Related]
2. Drugged Driving in Wisconsin: Oral Fluid Versus Blood. Edwards LD; Smith KL; Savage T J Anal Toxicol; 2017 Jul; 41(6):523-529. PubMed ID: 28830121 [TBL] [Abstract][Full Text] [Related]
3. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls. Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. Cone EJ; Clarke J; Tsanaclis L J Anal Toxicol; 2007 Oct; 31(8):424-33. PubMed ID: 17988455 [TBL] [Abstract][Full Text] [Related]
6. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France. Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427 [TBL] [Abstract][Full Text] [Related]
7. Oral Cavity Fluid as an Investigative Approach for Qualitative and Quantitative Evaluations of Drugs in Postmortem Subjects. Reisinger AJ; Miller AC; Shaw LA; Champion JL; Neiswonger MA J Anal Toxicol; 2019 Jul; 43(6):444-451. PubMed ID: 31062851 [TBL] [Abstract][Full Text] [Related]
8. A Novel Oral Fluid Assay (LC-QTOF-MS) for the Detection of Fentanyl and Clandestine Opioids in Oral Fluid After Reported Heroin Overdose. Griswold MK; Chai PR; Krotulski AJ; Friscia M; Chapman BP; Varma N; Boyer EW; Logan BK; Babu KM J Med Toxicol; 2017 Dec; 13(4):287-292. PubMed ID: 28971325 [TBL] [Abstract][Full Text] [Related]
9. A new LC-MS/MS confirmation method for the determination of 17 drugs of abuse in oral fluid and its application to real samples. Bassotti E; Merone GM; D'Urso A; Savini F; Locatelli M; Tartaglia A; Dossetto P; D'Ovidio C; de Grazia U Forensic Sci Int; 2020 Jul; 312():110330. PubMed ID: 32480284 [TBL] [Abstract][Full Text] [Related]
10. Opioids in oral fluid of Spanish drivers. Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744 [TBL] [Abstract][Full Text] [Related]
11. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs. Magura S; Lee-Easton MJ; Abu-Obaid R; Reed P; Allgaier B; Amaratunga P; Lorenz-Lemberg B; Levitas M; Achtyes ED Drug Alcohol Depend; 2023 Sep; 250():110894. PubMed ID: 37481872 [TBL] [Abstract][Full Text] [Related]
12. Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs. Heltsley R; DePriest A; Black DL; Robert T; Marshall L; Meadors VM; Caplan YH; Cone EJ J Anal Toxicol; 2011 Oct; 35(8):529-40. PubMed ID: 22004671 [TBL] [Abstract][Full Text] [Related]
13. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine. Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701 [TBL] [Abstract][Full Text] [Related]
14. Detection of Drugs in Oral Fluid Samples Using a Commercially Available Collection Device: Agreement with Urine Testing and Evaluation of A and B Samples Obtained from Employees at Different Workplace Settings with Uncontrolled Sampling Procedures. Zheng Y; Sparve E; Sparring S; Bergström M J Anal Toxicol; 2021 Jan; 44(9):1004-1011. PubMed ID: 32128555 [TBL] [Abstract][Full Text] [Related]
15. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure. Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162 [TBL] [Abstract][Full Text] [Related]
16. Quantification of fentanyl analogs in oral fluid using LC-QTOF-MS. Palmquist KB; Swortwood MJ J Forensic Sci; 2021 Sep; 66(5):1871-1878. PubMed ID: 34287912 [TBL] [Abstract][Full Text] [Related]
17. Suitability of SoToxa® Oral Fluid Screening Over Time: Re-Examination of Drugged Driving in Wisconsin. Savage T; Sanders T; Pieters R; Miles A; Barkholtz H J Anal Toxicol; 2022 Oct; 46(8):825-834. PubMed ID: 35767245 [TBL] [Abstract][Full Text] [Related]
18. Urine toxicology screening by liquid chromatography time-of-flight mass spectrometry in a quaternary hospital setting. Pope JD; Black MJ; Drummer OH; Schneider HG Clin Biochem; 2021 Sep; 95():66-72. PubMed ID: 33989561 [TBL] [Abstract][Full Text] [Related]
19. Quantitative Analysis of Novel Synthetic Opioids, Morphine and Buprenorphine in Oral Fluid by LC-MS-MS. Truver MT; Swortwood MJ J Anal Toxicol; 2018 Oct; 42(8):554-561. PubMed ID: 30371839 [TBL] [Abstract][Full Text] [Related]
20. General unknown screening in hair by liquid chromatography-hybrid quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Broecker S; Herre S; Pragst F Forensic Sci Int; 2012 May; 218(1-3):68-81. PubMed ID: 22036310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]